The case surrounding Wockhardt’s’ codeine creation practices has sparked a significant controversy. Reports surfaced suggesting possible data manipulation and insufficient oversight during the drug's production. This led to agency scrutiny from the US Food and Drug Administration, culminating in sales restrictions and prompting serious question… Read More